Science ❯ Biotechnology

Protein Engineering

Artificial Intelligence AI in Biotech Pharmaceuticals AI in Drug Discovery Antibody Technology Artificial Proteins Immunology Antibody Development Albumin Fusion Monoclonal Antibodies Therapeutics Laboratory Testing Miniproteins Therapeutic Technologies Molecular Design AI in Biotechnology

DeepMind Introduces SynthID Bio, a Watermark for AI‑Designed Proteins

The proof-of-concept embeds a hidden, verifiable signal inside protein sequences to help trace AI origin while preserving biological function.

AI-Designed Miniproteins Target GPCRs in Nature Study

Sanofi Licenses Kali’s Tri-Specific Autoimmune Antibody KT501 in Deal Worth Up to $1.23 Billion

Microsoft-Led Study Exposes AI Biosecurity Gap as Patches Lift Detection to 97%

AbbVie Extends Rinvoq U.S. Exclusivity to 2037 as AI Biotechs Move From Models to Medicines

AI Drives Next-Generation Melanoma Immunotherapies Toward In Vivo Testing

Australian AI Platform Designs Protein That Kills Drug-Resistant E. coli